These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 16111092)
1. Reducing the incidence and severity of post ERCP pancreatitis. Murray WR Scand J Surg; 2005; 94(2):112-6. PubMed ID: 16111092 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study. Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R; Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis. Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Freeman ML Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Das A; Singh P; Sivak MV; Chak A Gastrointest Endosc; 2007 Jun; 65(7):960-8. PubMed ID: 17331513 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results. Saad AM; Fogel EL; McHenry L; Watkins JL; Sherman S; Lazzell-Pannell L; Lehman GA Gastrointest Endosc; 2008 Feb; 67(2):255-61. PubMed ID: 18028920 [TBL] [Abstract][Full Text] [Related]
12. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547 [TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study. Yaghoobi M; Pauls Q; Durkalski V; Romagnuolo J; Fogel EL; Tarnasky PR; Aliperti G; Freeman ML; Kozarek RA; Jamidar PA; Wilcox CM; Elta GH; Hawes RH; Wood-Williams A; Cotton PB Endoscopy; 2015 Oct; 47(10):884-90. PubMed ID: 26165739 [TBL] [Abstract][Full Text] [Related]
15. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Fazel A; Quadri A; Catalano MF; Meyerson SM; Geenen JE Gastrointest Endosc; 2003 Mar; 57(3):291-4. PubMed ID: 12612504 [TBL] [Abstract][Full Text] [Related]
16. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis. Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185 [TBL] [Abstract][Full Text] [Related]
17. Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done? Hauser G; Milosevic M; Stimac D; Zerem E; Jovanović P; Blazevic I World J Gastroenterol; 2015 Jan; 21(4):1069-80. PubMed ID: 25632179 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population. Troendle DM; Abraham O; Huang R; Barth BA Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874 [TBL] [Abstract][Full Text] [Related]
19. ERCP and prophylactic pancreatic stents: raising the bar, reducing the pain. Silverman WB Gastrointest Endosc; 2007 Jun; 65(7):969-70. PubMed ID: 17531629 [No Abstract] [Full Text] [Related]
20. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study. Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]